Vitamin D deficiency and a trial fibrillation

International Journal of Cardiology

Volumn 184, Issue 1, 2015, Pages 159-162

  Thompson, Joseph ^a   Nitiahpapand, Rynda ^a   Bhatti, Prashan ^a   Kourliouros, Antonios ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Antioxidants; Atrial fibrillation; Cardiac arrhythmias; Oxidative stre ; Vitamin D deficiency

Indexed keywords

C REACTIVE PROTEIN; CALCITRIOL; REACTIVE OXYGEN METABOLITE; VITAMIN D;

ACTION POTENTIAL AMPLITUDE; ACTION POTENTIAL DURATION; ANTIARRHYTHMIC ACTIVITY; ATRIAL FIBRILLATION; CALCIUM TRANSPORT; DISEASE ASSOCIATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; EXPERIMENTAL STUDY; FOLLOW UP; HEART PROTECTION; HUMAN; MEMBRANE STEADY POTENTIAL; NONHUMAN; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINUS RHYTHM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WINTER; ANIMAL; BLOOD; COMPLICATION; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; ATRIAL FIBRILLATION; HUMANS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84933507697     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.02.012     Document Type: Review

References (27)

1. S. DeWilde, et al., Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care, Heart 92 (8) (2006) 1064-1070.
2. Y. Miyasaka, et al., Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence, Circulation 114 (2) (2006) 119-125.
3. L. Harling, et al., Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials, Heart 97 (20) (2011) 1636-1642.
4. J.P. Forman, et al., Plasma 25-hydroxyvitamin D levels and risk of incident hypertension, Hypertension 49 (5) (2007) 1063-1069.
5. P. Brondum-Jacobsen, et al., 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: Population-based study and metaanalyses of 18 and 17 studies, Arterioscler. Thromb. Vasc. Biol. 32 (11) (2012) 2794-2802.
6. K.E. Poole, et al., Reduced vitamin D in acute stroke, Stroke 37 (1) (2006) 243-245.
7. Y.C. Li, Vitamin D regulation of the renin-angiotensin system, J. Cell. Biochem. 88 (2) (2003) 327-331.
8. D.G. Gardner, S. Chen, D.J. Glenn, Vitamin D and the heart, Am. J. Physiol. Regul. Integr. Comp. Physiol. 305 (9) (2013) R969-R977.
9. S. Chen, et al., Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy, Circulation 124 (17) (2011) 1838-1847.
10. W. Xiang, et al., Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems, Am. J. Physiol. Endocrinol. Metab. 288 (1) (2005) E125-E132.
11. P. Mancuso, et al., 1, 25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failureprone (cp/+) rats independent of changes in serum leptin, J. Cardiovasc. Pharmacol. 51 (6) (2008) 559-564.
12. N.F. Murphy, et al., Seasonal variation in morbidity and mortality related to atrial fibrillation, Int. J. Cardiol. 97 (2) (2004) 283-288.
13. L. Frost, et al., Seasonal variation in hospital discharge diagnosis of atrial fibrillation: A population-based study, Epidemiology 13 (2) (2002) 211-215.
14. A.B. Shoben, et al., Seasonal variation in 25-hydroxyvitamin D concentrations in the cardiovascular health study, Am. J. Epidemiol. 174 (12) (2011) 1363-1372.
15. A. Gluszak, et al., Episodes of atrial fibrillation and meteorological conditions, Kardiol. Pol. 66 (9) (2008) 958-963 (discußion 964-5).
16. D.A. Hanafy, et al., Electromechanical effects of 1, 25-dihydroxyvitamin d with antiatrial fibrillation activities, J. Cardiovasc. Electrophysiol. 25 (3) (2014) 317-323.
17. M. Demir, U. Uyan, M.Melek, The effects of vitamin D deficiency on atrial fibrillation, Clin. Appl. Thromb. Hemost. 20 (1) (2014) 98-103.
18. F. Qayyum, et al., Vitamin D deficiency is unrelated to type of atrial fibrillation and its complications, Dan. Med. J. 59 (9) (2012) A4505.
19. M. Rienstra, et al., Vitamin D status is not related to development of atrial fibrillation in the community, Am. Heart J. 162 (3) (2011) 538-541.
20. M.B. Smith, et al., Abstract 14699: vitamin D exceß is significantly aßociated with risk of atrial fibrillation, Circulation 124 (2011) A14699.
21. W.R. Chen, et al., Relation of Low vitamin D to nonvalvular persistent atrial fibrillation in Chinese patients, Ann Noninvasive Electrocardiol 19 (2) (2014) 166-173.
22. D. Pickar, et al., Clinical and biologic response to clozapine in patients with schizophrenia. Croßover comparison with fluphenazine, Arch. Gen. Psychiatry 49 (5) (1992) 345-353.
23. A.C. Roß, The 2011 report on dietary reference intakes for calcium and vitamin D, Public Health Nutr. 14 (5) (2011) 938-939.
24. G.D. Carter, Accuracy of 25-hydroxyvitamin D aßays: confronting the ißues, Curr. Drug Targets 12 (1) (2011) 19-28.
25. A.L. Christensen, et al., Seasonality, incidence and prognosis in atrial fibrillation and stroke in Denmark and New Zealand, BMJ Open 2 (4) (2012).
26. A. Gluszak, et al., May sunshine protect women against paroxysms of atrial fibrillation? Tohoku J. Exp. Med. 219 (4) (2009) 303-306.
27. Y. Wang, et al., Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: Insights from simulations based on serum 25-hydroxyvitamin d, Am. J. Epidemiol. 170 (1) (2009) 88-94.